Halozyme Therapeutics, Inc (HALO) Sec Form 8K
Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 8K
19 articles, transcripts, and reports
Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 8K
Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Management Update
Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Call dated Feb. 17, 2026 Corporate Participants: Tram Bui — Head of...
Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Other Release
Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Corporate Conference
Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Corporate Conference
Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 10K
Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 8K
Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Other Release
Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Release